News
Nano-Immunotherapy Offers New Possibilities in Treating Atherosclerosis
New research in nano-immunotherapy offers new possibilities in the treatment of atherosclerosis, which is a thickening or hardening of the…
Read MoreResearch Takes Center Stage at Lupus Awareness Event
May 19, 2023 The Lupus and Allied Diseases Association, Inc., and MMRI teamed up on May 19 at the MMRI…
Read MorePerspectives on Choosing a Career in Science Research
MMRI was featured in a discussion about the types and methods of research, in an article for those considering a…
Read MoreGriffin Charitable Foundation Donates $71,000 to MMRI
The Griffin Charitable Foundation of Rome, New York, donated $71,000 to fund cutting-edge technology at MMRI. The donation will be…
Read MoreDr. Zhiqiang Lin Radio Interview Spotlights Heart Research
Dr. Zhiqiang Lin, Assistant Professor and Gene Therapy Core Manager at MMRI, discussed his groundbreaking research about how COVID impacts…
Read MoreSuper Bowl Ad Reaches New Audience for MMRI
February 12, 2023 The MMRI reached a new nationwide audience with its “Every Heartbeat Counts” advertisement that appeared at Super…
Read MoreNano Drug Delivery Offers New Possibilities for Pulmonary Fibrosis
Jason McCarthy, Ph.D., Scientific Operations Director and Associate Professor at MMRI, led new research in nano drug delivery that reveals…
Read MoreHealthline: Benefits and Concerns of Genetic Testing
December 14, 2022: Dr. Nathan Tucker of the Masonic Medical Research Institute (MMRI), an expert on genomics, was quoted in…
Read MoreNew ‘Kessinger Lab’ Marks Continued Expansion of the MMRI
The Masonic Medical Research Institute (MMRI) recently promoted Chase Kessinger, Ph.D., to assistant professor and added a new lab to…
Read MoreScientists Work to Identify, Treat Heart Disease
September 21, 2022 Spectrum News (video) https://spectrumlocalnews.com/nys/binghamton/news/2022/10/13/utica-scientists-finding-new-way-to-identify–treat-heart-disease (Click here for the PDF) Utica scientists work to identify, treat…
Read More